Submitted by: Submitted by jayram
Views: 10
Words: 585
Pages: 3
Category: Business and Industry
Date Submitted: 05/11/2016 03:03 AM
RnRMarketResearch.com includes Global Cancer Immunotherapies Market 2016-2020 is new research report. Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market.
Complete report available @ http://www.rnrmarketresearch.com/global-cancer-immunotherapies-market-2016-2020-market-report.html?utm_source=Fpro&utm_medium=Promotion&utm_campaign=SEO
The analysts forecast global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020. This report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.
The market is divided into the following segments based on geography: APAC, America, ROW
Purchase a Copy of the Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=539915&utm_source=Fpro&utm_medium=Promotion&utm_campaign=SEO (Single User License - US $2500)
The report, Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors : Amgen, Bristol-Myers Squibb, F. Hoffmann-La Roche, GlaxoSmithKline, Merck, Takeda Pharmaceuticals
Other prominent vendors : AbbVie, ADC Therapeutics, Agensys, Astellas, AstraZeneca, Bayer, Biogen, Biotech Pharmaceutical, Boehringer-Ingelheim, Celgene, Celldex Therapeutics, Chugai Pharmaceutical, CTI Biopharma, Daiichi Sankyo, Eli Lilly, Fortress Biotech, Genmab, Immunomedics, Intas , harmaceuticals, Janssen...